,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,D,2019-09-18 16:45:28,2019-09-16,ALDR,Smith Jeffrey T L,MD,M - OptEx,4.15,32728,5272,-119%,135902.0,,,,,ALDR
1,D,2019-09-18 16:45:28,2019-09-16,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,18.44,-32728,5272,-86%,-603504.0,,,,,ALDR
2,,2019-04-25 18:55:14,2019-04-23,ALDR,Hassler Randal,"EVP, Pharmaceutical Ops.",A - Grant,0.0,7172,5434,-413%,0.0,,,,,ALDR
3,,2019-04-25 18:55:14,2019-04-25,ALDR,Hassler Randal,"EVP, Pharmaceutical Ops.",S - Sale,13.85,-1738,5434,-24%,-24067.0,,,,,ALDR
4,,2019-04-25 18:53:24,2019-04-23,ALDR,Benedict Larry,"EVP, PAO",A - Grant,0.0,7055,39728,+22%,0.0,,,,,ALDR
5,,2019-04-25 18:53:24,2019-04-25,ALDR,Benedict Larry,"EVP, PAO",S - Sale,13.65,-1734,39728,-4%,-23662.0,,,,,ALDR
6,,2019-04-25 18:51:46,2019-04-23,ALDR,Smith Jeffrey T L,MD,A - Grant,0.0,9288,5272,-231%,0.0,,,,,ALDR
7,,2019-04-25 18:51:46,2019-04-25,ALDR,Smith Jeffrey T L,MD,D - Sale to issuer,13.73,-4847,5272,-48%,-66526.0,,,,,ALDR
8,,2019-04-25 18:49:27,2019-04-23,ALDR,Lavelle Erin,COO,A - Grant,0.0,5842,4408,-407%,0.0,,,,,ALDR
9,,2019-04-25 18:49:27,2019-04-25,ALDR,Lavelle Erin,COO,S - Sale,13.67,-1434,4408,-25%,-19599.0,,,,,ALDR
10,,2019-04-25 18:43:22,2019-04-23,ALDR,Bucher James B,"EVP, GC",A - Grant,0.0,7810,9809,+391%,0.0,,,,,ALDR
11,,2019-04-25 18:43:22,2019-04-25,ALDR,Bucher James B,"EVP, GC",S - Sale,13.85,-1897,9809,-16%,-26281.0,,,,,ALDR
12,,2019-03-06 16:24:24,2019-03-04,ALDR,"Redmile Group, LLC",Dir,A - Grant,11.5,1739130,8244896,+27%,19999995.0,,,,,ALDR
13,D,2019-02-08 16:47:56,2018-11-30,ALDR,Latham John A,Chief Scientific Officer,A - Grant,9.35,487,244180,0%,4553.0,,,,,ALDR
14,D,2019-02-08 16:43:46,2018-11-30,ALDR,Bucher James B,"EVP, GC",A - Grant,9.35,273,3896,+8%,2553.0,,,,,ALDR
15,DM,2019-02-08 16:41:48,2018-05-31,ALDR,Benedict Larry,"EVP, PAO",A - Grant,9.35,2273,34407,+7%,21253.0,,,,,ALDR
16,D,2018-12-04 18:39:08,2018-12-03,ALDR,Smith Jeffrey T L,MD,M - OptEx,0.99,5044,831,-120%,4994.0,,,,,ALDR
17,D,2018-12-04 18:39:08,2018-12-03,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,13.84,-5044,831,-86%,-69826.0,,,,,ALDR
18,D,2018-11-27 17:35:29,2018-05-31,ALDR,Bucher James B,"SVP, GC",A - Grant,9.35,2000,3623,+123%,18700.0,,,,,ALDR
19,D,2018-11-05 17:47:54,2018-11-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,0.99,5040,831,-120%,4990.0,,,,,ALDR
20,D,2018-11-05 17:47:54,2018-11-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,13.42,-5040,831,-86%,-67637.0,,,,,ALDR
21,D,2018-11-05 17:43:15,2018-11-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,9.12,25002,243693,+11%,227954.0,,,,,ALDR
22,D,2018-11-05 17:43:15,2018-11-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,13.42,-25002,243693,-9%,-335589.0,,,,,ALDR
23,D,2018-10-03 18:33:25,2018-10-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,0.99,5040,831,-120%,4990.0,,,,,ALDR
24,D,2018-10-03 18:33:25,2018-10-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,15.54,-5040,831,-86%,-78329.0,,,,,ALDR
25,D,2018-10-03 18:31:50,2018-10-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,4.36,24999,243693,+11%,109108.0,,,,,ALDR
26,D,2018-10-03 18:31:50,2018-10-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,15.44,-24999,243693,-9%,-386006.0,,,,,ALDR
27,D,2018-09-06 17:08:33,2018-09-04,ALDR,Smith Jeffrey T L,MD,M - OptEx,0.99,5040,831,-120%,4990.0,,,,,ALDR
28,D,2018-09-06 17:08:33,2018-09-04,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,18.0,-5040,831,-86%,-90699.0,,,,,ALDR
29,D,2018-09-06 17:05:39,2018-09-04,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,3.47,24999,243693,+11%,86622.0,,,,,ALDR
30,D,2018-09-06 17:05:39,2018-09-04,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,17.99,-24999,243693,-9%,-449680.0,,,,,ALDR
31,D,2018-08-02 17:48:16,2018-08-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,0.99,5040,831,-120%,4990.0,,,,,ALDR
32,D,2018-08-02 17:48:16,2018-08-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,19.54,-5040,831,-86%,-98489.0,,,,,ALDR
33,D,2018-08-02 17:40:08,2018-08-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,3.47,24999,243693,+11%,86622.0,,,,,ALDR
34,D,2018-08-02 17:40:08,2018-08-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,19.55,-24999,243693,-9%,-488768.0,,,,,ALDR
35,D,2018-07-03 17:28:10,2018-07-02,ALDR,Smith Jeffrey T L,MD,M - OptEx,1.38,12161,831,-107%,16739.0,,,,,ALDR
36,D,2018-07-03 17:28:10,2018-07-02,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,15.49,-12161,831,-94%,-188364.0,,,,,ALDR
37,D,2018-07-03 17:22:36,2018-07-02,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,3.47,24999,243693,+11%,86622.0,,,,,ALDR
38,D,2018-07-03 17:22:36,2018-07-02,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,15.48,-24999,243693,-9%,-387002.0,,,,,ALDR
39,D,2018-06-05 17:43:41,2018-06-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,4.37,24999,243693,+11%,109121.0,,,,,ALDR
40,D,2018-06-05 17:43:41,2018-06-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,17.86,-24999,243693,-9%,-446356.0,,,,,ALDR
41,D,2018-06-05 17:41:52,2018-06-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,1.38,12161,831,-107%,16739.0,,,,,ALDR
42,D,2018-06-05 17:41:52,2018-06-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,17.85,-12161,831,-94%,-217127.0,,,,,ALDR
43,D,2018-06-05 17:40:18,2018-06-01,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,0.99,22727,180189,+14%,22500.0,,,,,ALDR
44,D,2018-06-05 17:40:18,2018-06-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,17.84,-22727,180189,-11%,-405412.0,,,,,ALDR
45,D,2018-05-18 17:57:47,2018-05-16,ALDR,Smith Jeffrey T L,MD,M - OptEx,1.38,12161,831,-107%,16739.0,,,,,ALDR
46,D,2018-05-18 17:57:47,2018-05-16,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,15.03,-12161,831,-94%,-182758.0,,,,,ALDR
47,DM,2017-12-18 18:28:19,2017-05-31,ALDR,Latham John A,Chief Scientific Officer,A - Grant,10.9,805,243208,0%,8772.0,,,,,ALDR
48,D,2017-12-18 18:25:25,2017-11-30,ALDR,Bucher James B,"SVP, GC",A - Grant,9.35,1623,1623,New,15175.0,,,,,ALDR
49,D,2017-11-15 17:54:56,2017-11-13,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,1.65,16519,177932,+10%,27256.0,,,,,ALDR
50,D,2017-11-15 17:54:56,2017-11-13,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,10.8,-16519,177932,-8%,-178486.0,,,,,ALDR
51,D,2017-11-03 17:48:23,2017-11-01,ALDR,Siegall Clay B,Dir,M - OptEx,1.3,27270,31714,+614%,35496.0,,,,,ALDR
52,D,2017-10-18 18:20:14,2017-10-16,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,1.65,16520,177932,+10%,27258.0,,,,,ALDR
53,D,2017-10-18 18:20:14,2017-10-16,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,12.33,-16520,177932,-8%,-203703.0,,,,,ALDR
54,,2017-07-18 19:52:09,2017-07-18,ALDR,Yarno Wendy L,Dir,P - Purchase,10.0,5000,5000,New,50000.0,,,,,ALDR
55,,2017-07-18 19:50:48,2017-07-18,ALDR,Dow Stephen M,Dir,P - Purchase,10.0,25000,307190,+9%,250000.0,,,,,ALDR
56,D,2017-06-22 18:12:08,2017-06-20,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.99,585,831,+238%,579.0,,,,,ALDR
57,D,2017-06-22 18:12:08,2017-06-20,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,20.0,-585,831,-41%,-11700.0,,,,,ALDR
58,D,2017-02-13 18:10:38,2017-02-09,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.65,30000,115172,+35%,49500.0,0.0,-3.0,-5.0,,ALDR
59,D,2017-02-13 18:10:38,2017-02-09,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,25.03,-30000,115172,-21%,-750756.0,0.0,-3.0,-5.0,,ALDR
60,D,2017-01-31 17:32:05,2016-11-30,ALDR,Benedict Larry,"EVP, PAO",A - Grant,20.2,742,30989,+2%,14988.0,2.0,13.0,17.0,,ALDR
61,D,2017-01-31 17:23:42,2016-11-30,ALDR,Schatzman Randall C,"Pres, CEO",A - Grant,20.2,404,115172,0%,8161.0,2.0,13.0,17.0,,ALDR
62,D,2017-01-20 18:38:42,2017-01-18,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,1.65,1498,177932,+1%,2472.0,-4.0,-5.0,11.0,,ALDR
63,D,2017-01-20 18:38:42,2017-01-18,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,23.1,-1498,177932,-1%,-34599.0,-4.0,-5.0,11.0,,ALDR
64,DM,2017-01-09 17:49:00,2017-01-05,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,1.34,9516,177932,+6%,12741.0,0.0,-4.0,4.0,,ALDR
65,DM,2017-01-09 17:49:00,2017-01-05,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,23.01,-9516,177932,-5%,-218992.0,0.0,-4.0,4.0,,ALDR
66,D,2016-12-05 18:47:56,2016-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,1.65,3000,831,-138%,4950.0,1.0,-5.0,-4.0,,ALDR
67,D,2016-12-05 18:47:56,2016-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,22.78,-3000,831,-78%,-68328.0,1.0,-5.0,-4.0,,ALDR
68,D,2016-12-05 18:46:33,2016-12-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,3636,242403,+2%,5999.0,1.0,-5.0,-4.0,,ALDR
69,D,2016-12-05 18:46:33,2016-12-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,22.78,-3636,242403,-1%,-82812.0,1.0,-5.0,-4.0,,ALDR
70,D,2016-11-14 18:32:13,2016-11-09,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,10000,242200,+4%,16500.0,-3.0,-17.0,-37.0,,ALDR
71,D,2016-11-14 18:32:13,2016-11-09,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,30.18,-10000,242200,-4%,-301839.0,-3.0,-17.0,-37.0,,ALDR
72,D,2016-11-09 18:17:59,2016-11-07,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.65,10000,114768,+10%,16500.0,3.0,14.0,-31.0,-41.0,ALDR
73,D,2016-11-09 18:17:59,2016-11-07,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,25.16,-10000,114768,-8%,-251605.0,3.0,14.0,-31.0,-41.0,ALDR
74,D,2016-11-03 18:39:46,2016-11-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,1.65,3000,0,-100%,4950.0,8.0,30.0,2.0,-7.0,ALDR
75,D,2016-11-03 18:39:46,2016-11-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,24.34,-3000,0,-100%,-73032.0,8.0,30.0,2.0,-7.0,ALDR
76,,2016-10-19 17:51:01,2016-10-17,ALDR,Litton Mark James,Chief Business Officer,S - Sale,27.5,-6000,125567,-5%,-164998.0,7.0,0.0,5.0,-26.0,ALDR
77,D,2016-10-11 16:56:27,2016-05-31,ALDR,Benedict Larry,"EVP, PAO",A - Grant,8.5,2000,30247,+7%,17000.0,-6.0,-8.0,-14.0,-33.0,ALDR
78,D,2016-10-05 19:02:54,2016-10-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,1.65,3000,0,-100%,4950.0,-4.0,-4.0,-25.0,-39.0,ALDR
79,D,2016-10-05 19:02:54,2016-10-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,31.14,-3000,0,-100%,-93415.0,-4.0,-4.0,-25.0,-39.0,ALDR
80,D,2016-10-05 18:54:32,2016-10-03,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.27,8181,114768,+8%,10349.0,-4.0,-4.0,-25.0,-39.0,ALDR
81,D,2016-10-05 18:54:32,2016-10-03,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,31.15,-8181,114768,-7%,-254811.0,-4.0,-4.0,-25.0,-39.0,ALDR
82,D,2016-10-05 18:53:02,2016-10-03,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,10000,242200,+4%,16500.0,-4.0,-4.0,-25.0,-39.0,ALDR
83,D,2016-10-05 18:53:02,2016-10-03,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,31.32,-10000,242200,-4%,-313152.0,-4.0,-4.0,-25.0,-39.0,ALDR
84,D,2016-09-06 18:39:21,2016-09-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,10000,242200,+4%,16500.0,1.0,-1.0,-2.0,-32.0,ALDR
85,D,2016-09-06 18:39:21,2016-09-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,32.49,-10000,242200,-4%,-324949.0,1.0,-1.0,-2.0,-32.0,ALDR
86,D,2016-09-06 18:36:22,2016-09-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.27,10000,114768,+10%,12650.0,1.0,-1.0,-2.0,-32.0,ALDR
87,D,2016-09-06 18:36:22,2016-09-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,32.48,-10000,114768,-8%,-324820.0,1.0,-1.0,-2.0,-32.0,ALDR
88,D,2016-09-06 18:34:24,2016-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,1.65,3000,0,-100%,4950.0,1.0,-1.0,-2.0,-32.0,ALDR
89,D,2016-09-06 18:34:24,2016-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,32.49,-3000,0,-100%,-97483.0,1.0,-1.0,-2.0,-32.0,ALDR
90,D,2016-08-17 18:55:41,2016-08-15,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,1.65,3000,0,-100%,4950.0,1.0,10.0,7.0,-20.0,ALDR
91,D,2016-08-17 18:55:41,2016-08-15,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,31.17,-3000,0,-100%,-93512.0,1.0,10.0,7.0,-20.0,ALDR
92,D,2016-08-03 18:42:07,2016-08-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.27,10000,229552,+5%,12650.0,-1.0,-2.0,5.0,-35.0,ALDR
93,D,2016-08-03 18:42:07,2016-08-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,31.15,-10000,229552,-4%,-311513.0,-1.0,-2.0,5.0,-35.0,ALDR
94,D,2016-08-03 18:33:10,2016-08-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,10000,242200,+4%,16500.0,-1.0,-2.0,5.0,-35.0,ALDR
95,D,2016-08-03 18:33:10,2016-08-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,31.19,-10000,242200,-4%,-311948.0,-1.0,-2.0,5.0,-35.0,ALDR
96,DM,2016-07-28 18:37:15,2016-07-26,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,10000,242200,+4%,16500.0,5.0,3.0,4.0,-35.0,ALDR
97,DM,2016-07-28 18:37:15,2016-07-26,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,30.14,-10000,242200,-4%,-301415.0,5.0,3.0,4.0,-35.0,ALDR
98,D,2016-07-27 18:19:26,2016-07-25,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.27,10000,114768,+10%,12650.0,0.0,-2.0,2.0,-35.0,ALDR
99,D,2016-07-27 18:19:26,2016-07-25,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,28.08,-10000,114768,-8%,-280805.0,0.0,-2.0,2.0,-35.0,ALDR
100,D,2016-07-14 19:14:48,2016-07-12,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,0.39,25000,183567,+16%,9625.0,1.0,4.0,20.0,-20.0,ALDR
101,,2016-06-15 19:02:34,2016-06-13,ALDR,Litton Mark James,Chief Business Officer,S - Sale,28.94,-6000,102567,-6%,-173664.0,-1.0,-11.0,-10.0,-23.0,ALDR
102,D,2016-06-07 19:32:10,2016-06-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,1.27,16090,0,-100%,20354.0,-2.0,-7.0,-16.0,-26.0,ALDR
103,D,2016-06-07 19:32:10,2016-06-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,30.2,-16090,0,-100%,-485933.0,-2.0,-7.0,-16.0,-26.0,ALDR
104,D,2016-06-03 19:16:18,2016-06-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.27,10000,114768,+10%,12650.0,7.0,0.0,-11.0,-19.0,ALDR
105,D,2016-06-03 19:16:18,2016-06-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,29.65,-10000,114768,-8%,-296544.0,7.0,0.0,-11.0,-19.0,ALDR
106,D,2016-06-03 19:11:59,2016-06-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.65,10000,242200,+4%,16500.0,7.0,0.0,-11.0,-19.0,ALDR
107,D,2016-06-03 19:11:59,2016-06-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,30.02,-10000,242200,-4%,-300216.0,7.0,0.0,-11.0,-19.0,ALDR
108,DM,2016-06-01 19:53:44,2016-05-27,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.35,40000,242200,+20%,54100.0,6.0,3.0,-19.0,-21.0,ALDR
109,DM,2016-06-01 19:53:44,2016-05-27,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,30.04,-40000,242200,-14%,-1201619.0,6.0,3.0,-19.0,-21.0,ALDR
110,DM,2016-06-01 19:49:53,2016-05-27,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,0.39,25000,164567,+18%,9625.0,6.0,3.0,-19.0,-21.0,ALDR
111,DM,2016-06-01 19:49:53,2016-05-27,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,30.05,-25000,164567,-13%,-751259.0,6.0,3.0,-19.0,-21.0,ALDR
112,DM,2016-05-24 20:13:45,2016-05-20,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,1.27,10000,112947,+10%,12650.0,-2.0,6.0,-11.0,1.0,ALDR
113,DM,2016-05-24 20:13:45,2016-05-20,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,28.02,-10000,112947,-8%,-280175.0,-2.0,6.0,-11.0,1.0,ALDR
114,DM,2016-04-18 18:40:11,2016-04-14,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,0.68,30000,112947,+36%,20350.0,-2.0,3.0,-9.0,1.0,ALDR
115,DM,2016-04-18 18:40:11,2016-04-14,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,28.07,-30000,112947,-21%,-841967.0,-2.0,3.0,-9.0,1.0,ALDR
116,D,2016-02-02 19:00:44,2015-11-30,ALDR,Benedict Larry,SVP Finance,A - Grant,8.5,2000,28247,+8%,17000.0,-4.0,-20.0,-15.0,22.0,ALDR
117,D,2016-01-06 20:40:45,2016-01-04,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,0.39,25000,163718,+18%,9625.0,-4.0,-9.0,-24.0,-17.0,ALDR
118,D,2016-01-06 20:40:45,2016-01-04,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,31.4,-25000,163718,-13%,-784951.0,-4.0,-9.0,-24.0,-17.0,ALDR
119,D,2016-01-06 20:37:58,2016-01-04,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,1.27,10000,241726,+4%,12650.0,-4.0,-9.0,-24.0,-17.0,ALDR
120,D,2016-01-06 20:37:58,2016-01-04,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,31.41,-10000,241726,-4%,-314137.0,-4.0,-9.0,-24.0,-17.0,ALDR
121,D,2016-01-06 20:35:56,2016-01-04,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,0.39,10000,111579,+10%,3850.0,-4.0,-9.0,-24.0,-17.0,ALDR
122,D,2016-01-06 20:35:56,2016-01-04,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,31.47,-10000,111579,-8%,-314747.0,-4.0,-9.0,-24.0,-17.0,ALDR
123,D,2015-12-03 21:02:48,2015-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,4272,0,-100%,1645.0,1.0,-4.0,-11.0,-17.0,ALDR
124,D,2015-12-03 21:02:48,2015-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,37.24,-4272,0,-100%,-159104.0,1.0,-4.0,-11.0,-17.0,ALDR
125,D,2015-12-03 21:00:57,2015-12-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4550,241726,+2%,1752.0,1.0,-4.0,-11.0,-17.0,ALDR
126,D,2015-12-03 21:00:57,2015-12-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,37.24,-4550,241726,-2%,-169452.0,1.0,-4.0,-11.0,-17.0,ALDR
127,D,2015-12-03 20:59:08,2015-12-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,0.39,10000,111579,+10%,3850.0,1.0,-4.0,-11.0,-17.0,ALDR
128,D,2015-12-03 20:59:08,2015-12-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,37.24,-10000,111579,-8%,-372431.0,1.0,-4.0,-11.0,-17.0,ALDR
129,,2015-12-02 17:56:19,2015-11-30,ALDR,Dow Stephen M,Dir,S - Sale,37.11,-88,282190,0%,-3266.0,-4.0,-6.0,-12.0,-14.0,ALDR
130,D,2015-11-04 21:44:52,2015-11-02,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,241265,+2%,1750.0,-3.0,-9.0,-7.0,-35.0,ALDR
131,D,2015-11-04 21:44:52,2015-11-02,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,33.69,-4545,241265,-2%,-153137.0,-3.0,-9.0,-7.0,-35.0,ALDR
132,D,2015-11-04 21:42:25,2015-11-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,-3.0,-9.0,-7.0,-35.0,ALDR
133,D,2015-11-04 21:42:25,2015-11-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,33.67,-3900,0,-100%,-131299.0,-3.0,-9.0,-7.0,-35.0,ALDR
134,D,2015-11-04 21:40:03,2015-11-02,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,0.39,10000,109921,+10%,3850.0,-3.0,-9.0,-7.0,-35.0,ALDR
135,D,2015-11-04 21:40:03,2015-11-02,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,33.71,-10000,109921,-8%,-337066.0,-3.0,-9.0,-7.0,-35.0,ALDR
136,D,2015-10-05 18:21:26,2015-10-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,241265,+2%,1750.0,-8.0,-19.0,0.0,-32.0,ALDR
137,D,2015-10-05 18:21:26,2015-10-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,32.26,-4545,241265,-2%,-146603.0,-8.0,-19.0,0.0,-32.0,ALDR
138,,2015-10-05 18:19:29,2015-10-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale,32.27,-7500,162919,-4%,-242002.0,-8.0,-19.0,0.0,-32.0,ALDR
139,D,2015-10-05 18:16:38,2015-10-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,-8.0,-19.0,0.0,-32.0,ALDR
140,D,2015-10-05 18:16:38,2015-10-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,32.25,-3900,0,-100%,-125778.0,-8.0,-19.0,0.0,-32.0,ALDR
141,D,2015-09-28 18:19:36,2015-09-24,ALDR,Benedict Larry,SVP Finance,M - OptEx,3.28,24981,26247,>999%,82060.0,-5.0,12.0,-3.0,-19.0,ALDR
142,D,2015-09-28 18:14:06,2015-09-24,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.99,31818,241265,+15%,31500.0,-5.0,12.0,-3.0,-19.0,ALDR
143,D,2015-09-28 18:11:37,2015-09-24,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,1.27,12764,170419,+8%,16146.0,-5.0,12.0,-3.0,-19.0,ALDR
144,D,2015-09-03 18:09:39,2015-09-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,209447,+2%,1750.0,1.0,2.0,-12.0,-49.0,ALDR
145,D,2015-09-03 18:09:39,2015-09-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,38.52,-4545,209447,-2%,-175059.0,1.0,2.0,-12.0,-49.0,ALDR
146,D,2015-09-03 18:01:12,2015-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,1.0,2.0,-12.0,-49.0,ALDR
147,D,2015-09-03 18:01:12,2015-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,38.5,-3900,0,-100%,-150165.0,1.0,2.0,-12.0,-49.0,ALDR
148,,2015-09-02 14:51:59,2015-08-31,ALDR,Srb Associates IX L.P.,Affiliate,S - Sale,38.75,-16218,88,-99%,-628460.0,6.0,6.0,-15.0,-48.0,ALDR
149,,2015-09-02 14:51:26,2015-08-31,ALDR,Dow Stephen M,Dir,S - Sale,38.75,-16218,282278,-5%,-628460.0,6.0,6.0,-15.0,-48.0,ALDR
150,M,2015-08-13 19:51:43,2015-08-11,ALDR,Srb Associates IX L.P.,Affiliate,S - Sale,40.23,-212467,1828276,-10%,-8548172.0,-3.0,-1.0,10.0,-44.0,ALDR
151,M,2015-08-13 19:50:48,2015-08-11,ALDR,Jaggers John V,Affiliate,S - Sale,40.23,-212467,20764,-91%,-8548172.0,-3.0,-1.0,10.0,-44.0,ALDR
152,M,2015-08-13 19:49:47,2015-08-11,ALDR,Dow Stephen M,Dir,S - Sale,40.23,-212467,298496,-42%,-8548172.0,-3.0,-1.0,10.0,-44.0,ALDR
153,D,2015-08-05 18:27:38,2015-08-03,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,209447,+2%,1750.0,-3.0,-11.0,-9.0,-46.0,ALDR
154,D,2015-08-05 18:27:38,2015-08-03,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,45.62,-4545,209447,-2%,-207322.0,-3.0,-11.0,-9.0,-46.0,ALDR
155,D,2015-08-05 18:26:03,2015-08-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,-3.0,-11.0,-9.0,-46.0,ALDR
156,D,2015-08-05 18:26:03,2015-08-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,45.64,-3900,0,-100%,-178003.0,-3.0,-11.0,-9.0,-46.0,ALDR
157,D,2015-07-06 18:05:47,2015-07-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,-7.0,-5.0,-14.0,-37.0,ALDR
158,D,2015-07-06 18:05:47,2015-07-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,51.18,-3900,0,-100%,-199616.0,-7.0,-5.0,-14.0,-37.0,ALDR
159,D,2015-07-06 18:02:34,2015-07-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,209447,+2%,1750.0,-7.0,-5.0,-14.0,-37.0,ALDR
160,D,2015-07-06 18:02:34,2015-07-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,51.13,-4545,209447,-2%,-232381.0,-7.0,-5.0,-14.0,-37.0,ALDR
161,,2015-07-06 17:59:58,2015-07-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale,51.1,-7500,157655,-5%,-383219.0,-7.0,-5.0,-14.0,-37.0,ALDR
162,D,2015-06-16 18:15:07,2015-06-12,ALDR,Benedict Larry,SVP Finance,M - OptEx,1.65,25454,1266,-105%,41999.0,-2.0,-3.0,6.0,-27.0,ALDR
163,D,2015-06-16 18:15:07,2015-06-12,ALDR,Benedict Larry,SVP Finance,S - Sale+OE,47.46,-25454,1266,-95%,-1208090.0,-2.0,-3.0,6.0,-27.0,ALDR
164,D,2015-06-08 19:05:34,2015-06-04,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,0.39,25000,165155,+18%,9625.0,0.0,2.0,5.0,-23.0,ALDR
165,D,2015-06-08 19:05:34,2015-06-04,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,44.27,-25000,165155,-13%,-1106853.0,0.0,2.0,5.0,-23.0,ALDR
166,D,2015-06-08 19:03:16,2015-06-04,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,25000,209447,+14%,9625.0,0.0,2.0,5.0,-23.0,ALDR
167,D,2015-06-08 19:03:16,2015-06-04,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,44.18,-25000,209447,-11%,-1104463.0,0.0,2.0,5.0,-23.0,ALDR
168,D,2015-06-03 20:04:13,2015-06-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,7.0,8.0,18.0,-13.0,ALDR
169,D,2015-06-03 20:04:13,2015-06-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,41.53,-3900,0,-100%,-161969.0,7.0,8.0,18.0,-13.0,ALDR
170,D,2015-06-03 19:59:00,2015-06-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,209447,+2%,1750.0,7.0,8.0,18.0,-13.0,ALDR
171,D,2015-06-03 19:59:00,2015-06-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,41.53,-4545,209447,-2%,-188757.0,7.0,8.0,18.0,-13.0,ALDR
172,D,2015-05-28 18:15:32,2015-05-26,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,0.39,50000,109921,+83%,19250.0,1.0,2.0,8.0,-13.0,ALDR
173,D,2015-05-28 18:15:32,2015-05-26,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,38.96,-50000,109921,-31%,-1948085.0,1.0,2.0,8.0,-13.0,ALDR
174,DM,2015-05-26 19:53:32,2015-05-21,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.06,61818,0,-100%,3400.0,5.0,5.0,20.0,-11.0,ALDR
175,DM,2015-05-26 19:53:32,2015-05-21,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,38.86,-61818,0,-100%,-2402523.0,5.0,5.0,20.0,-11.0,ALDR
176,AD,2015-05-21 18:30:30,2015-05-20,ALDR,Dow Stephen M,"Dir, 10%",S - Sale+OE,40.39,-8462,4313992,0%,-341820.0,0.0,8.0,19.0,-9.0,ALDR
177,D,2015-05-21 18:20:07,2015-05-19,ALDR,Benedict Larry,SVP Finance,M - OptEx,1.65,20000,663,-103%,33000.0,0.0,8.0,19.0,-9.0,ALDR
178,D,2015-05-21 18:20:07,2015-05-19,ALDR,Benedict Larry,SVP Finance,S - Sale+OE,38.86,-20000,663,-97%,-777196.0,0.0,8.0,19.0,-9.0,ALDR
179,,2015-05-21 17:53:56,2015-05-19,ALDR,Srb Associates IX L.P.,10%,S - Sale,37.02,-1136100,4048874,-22%,-42059899.0,0.0,8.0,19.0,-9.0,ALDR
180,,2015-05-21 15:34:21,2015-05-21,ALDR,Dow Stephen M,Dir,S - Sale,65.69,-20000,334072,-6%,-1313846.0,-5.0,4.0,15.0,-14.0,ALDR
181,D,2015-05-18 20:51:55,2015-05-14,ALDR,Siegall Clay B,Dir,M - OptEx,0.33,18181,4444,-132%,6000.0,-1.0,-3.0,17.0,-13.0,ALDR
182,DM,2015-05-18 20:51:55,2015-05-14,ALDR,Siegall Clay B,Dir,S - Sale+OE,37.62,-38181,4444,-90%,-1436495.0,-1.0,-3.0,17.0,-13.0,ALDR
183,D,2015-05-05 18:22:21,2015-05-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,4.0,27.0,57.0,17.0,ALDR
184,D,2015-05-05 18:22:21,2015-05-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,25.67,-3900,0,-100%,-100130.0,4.0,27.0,57.0,17.0,ALDR
185,D,2015-05-05 18:18:22,2015-05-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,208988,+2%,1750.0,4.0,27.0,57.0,17.0,ALDR
186,D,2015-05-05 18:18:22,2015-05-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,25.67,-4545,208988,-2%,-116663.0,4.0,27.0,57.0,17.0,ALDR
187,D,2015-04-03 18:02:54,2015-04-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,2.0,4.0,3.0,22.0,ALDR
188,D,2015-04-03 18:02:54,2015-04-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,27.43,-3900,0,-100%,-106995.0,2.0,4.0,3.0,22.0,ALDR
189,,2015-04-03 17:58:59,2015-04-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale,27.41,-7500,164359,-4%,-205553.0,2.0,4.0,3.0,22.0,ALDR
190,DM,2015-04-01 20:36:45,2015-03-30,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,19045,208988,+10%,7332.0,-2.0,2.0,-7.0,7.0,ALDR
191,DM,2015-04-01 20:36:45,2015-03-30,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,29.54,-19045,208988,-8%,-562518.0,-2.0,2.0,-7.0,7.0,ALDR
192,D,2015-03-04 17:35:58,2015-03-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,-3.0,3.0,3.0,46.0,ALDR
193,D,2015-03-04 17:35:58,2015-03-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,26.25,-3900,0,-100%,-102357.0,-3.0,3.0,3.0,46.0,ALDR
194,D,2015-03-04 17:32:33,2015-03-02,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,4545,208988,+2%,1750.0,-3.0,3.0,3.0,46.0,ALDR
195,D,2015-03-04 17:32:33,2015-03-02,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,26.26,-4545,208988,-2%,-119340.0,-3.0,3.0,3.0,46.0,ALDR
196,D,2015-01-28 18:09:21,2014-11-28,ALDR,Benedict Larry,SVP Finance,A - Grant,8.5,663,663,New,5636.0,-4.0,-9.0,-1.0,68.0,ALDR
197,DM,2015-01-28 18:01:38,2015-01-26,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,0.39,3900,0,-100%,1502.0,-4.0,-9.0,-1.0,68.0,ALDR
198,DM,2015-01-28 18:01:38,2015-01-26,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,28.01,-3900,0,-100%,-109237.0,-4.0,-9.0,-1.0,68.0,ALDR
199,DM,2015-01-28 17:56:52,2015-01-26,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,28.18,-7500,171859,-4%,-211334.0,-4.0,-9.0,-1.0,68.0,ALDR
200,DM,2015-01-28 17:54:35,2015-01-26,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,0.39,15045,208988,+8%,5792.0,-4.0,-9.0,-1.0,68.0,ALDR
201,DM,2015-01-28 17:54:35,2015-01-26,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,28.33,-15045,208988,-7%,-426286.0,-4.0,-9.0,-1.0,68.0,ALDR
202,DM,2015-01-28 17:51:52,2015-01-26,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,28.42,-100000,109921,-48%,-2842399.0,-4.0,-9.0,-1.0,68.0,ALDR
203,M,2014-11-25 18:13:57,2014-11-21,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale,16.08,-29090,0,-100%,-467853.0,1.0,3.0,52.0,150.0,ALDR
204,,2014-11-24 18:37:52,2014-11-20,ALDR,Litton Mark James,Chief Business Officer,S - Sale,15.63,-30000,178484,-14%,-469011.0,-1.0,-8.0,53.0,159.0,ALDR
205,D,2014-05-15 17:45:28,2014-05-13,ALDR,"Delphi Management Partners Vii, L.L.C.",10%,C - Converted deriv,0.0,2488532,5673599,-30%,0.0,0.0,-1.0,102.0,71.0,ALDR
206,D,2014-05-15 17:45:28,2014-05-13,ALDR,"Delphi Management Partners Vii, L.L.C.",10%,P - Purchase,10.0,350000,5673599,+7%,3500000.0,0.0,-1.0,102.0,71.0,ALDR
207,D,2014-05-15 17:43:10,2014-05-13,ALDR,Pakianathan Deepika,"Dir, 10%",C - Converted deriv,0.0,2488532,5673599,-30%,0.0,0.0,-1.0,102.0,71.0,ALDR
208,D,2014-05-15 17:43:10,2014-05-13,ALDR,Pakianathan Deepika,"Dir, 10%",P - Purchase,10.0,350000,5673599,+7%,3500000.0,0.0,-1.0,102.0,71.0,ALDR
209,D,2014-05-15 17:20:42,2014-05-13,ALDR,Siegall Clay B,Dir,C - Converted deriv,0.0,24444,24444,-50%,0.0,0.0,-1.0,102.0,71.0,ALDR
210,D,2014-05-15 17:18:15,2014-05-13,ALDR,Montgomery Alan Bruce,Dir,C - Converted deriv,0.0,6628,9628,-41%,0.0,0.0,-1.0,102.0,71.0,ALDR
211,D,2014-05-15 17:18:15,2014-05-13,ALDR,Montgomery Alan Bruce,Dir,P - Purchase,10.0,3000,9628,+45%,30000.0,0.0,-1.0,102.0,71.0,ALDR
212,D,2014-05-15 17:16:24,2014-05-13,ALDR,"H.I.G. Venture Partners Ii, L.P.",10%,C - Converted deriv,0.0,2581976,516395,-83%,0.0,0.0,-1.0,102.0,71.0,ALDR
213,D,2014-05-15 17:14:46,2014-05-13,ALDR,Davidson Aaron,Dir,C - Converted deriv,0.0,2581976,2581976,-50%,0.0,0.0,-1.0,102.0,71.0,ALDR
214,D,2014-05-15 17:09:52,2014-05-13,ALDR,Ventures West 8 Limited Partnership,10%,C - Converted deriv,0.0,3219528,3469528,-48%,0.0,0.0,-1.0,102.0,71.0,ALDR
215,D,2014-05-15 17:09:52,2014-05-13,ALDR,Ventures West 8 Limited Partnership,10%,P - Purchase,10.0,250000,3469528,+8%,2500000.0,0.0,-1.0,102.0,71.0,ALDR
216,D,2014-05-15 17:08:30,2014-05-13,ALDR,Bridger Gary,Dir,C - Converted deriv,0.0,3219528,3469528,-48%,0.0,0.0,-1.0,102.0,71.0,ALDR
217,D,2014-05-15 17:08:30,2014-05-13,ALDR,Bridger Gary,Dir,P - Purchase,10.0,250000,3469528,+8%,2500000.0,0.0,-1.0,102.0,71.0,ALDR
218,D,2014-05-15 12:08:56,2014-05-13,ALDR,Jaggers John V,10%,C - Converted deriv,0.0,5193436,5193436,-50%,0.0,0.0,-1.0,102.0,71.0,ALDR
219,D,2014-05-15 12:08:35,2014-05-13,ALDR,Dow Stephen M,"Dir, 10%",C - Converted deriv,0.0,5458554,5458554,-50%,0.0,0.0,-1.0,102.0,71.0,ALDR
220,D,2014-05-15 12:08:12,2014-05-13,ALDR,Srb Associates IX L.P.,10%,C - Converted deriv,0.0,5184974,5184974,-50%,0.0,0.0,-1.0,102.0,71.0,ALDR
221,D,2014-05-14 17:48:13,2014-05-13,ALDR,"Tpg Group Holdings (Sbs) Advisors, Inc.",10%,C - Converted deriv,0.0,2488533,2488533,-50%,0.0,0.0,1.0,86.0,68.0,ALDR
222,D,2014-05-14 16:24:17,2014-05-13,ALDR,Novo A/s,"SEE REMARKS, 10%",C - Converted deriv,0.0,2651183,3201183,-45%,0.0,0.0,1.0,86.0,68.0,ALDR
223,D,2014-05-14 16:24:17,2014-05-13,ALDR,Novo A/s,"SEE REMARKS, 10%",P - Purchase,10.0,550000,3201183,+21%,5500000.0,0.0,1.0,86.0,68.0,ALDR
